
Associate Director, Biostatistics Consultant – Oncology
Posted 11 hours ago

Posted 11 hours ago
This is a fully remote position, open to applicants in Europe.
• Offer strategic statistical direction across various development initiatives
• Collaborate effectively with Clinical Development, Regulatory, Medical, Commercial, and Portfolio teams
• Choose among superiority, non-inferiority, or equivalence trial designs
• Define and validate primary and secondary endpoints in oncology
• Create adaptive, seamless Phase II/III trials, including group sequential, basket, and umbrella designs
• Conduct calculations for sample size, power, and subgroup analysis
• Set go/no-go decision criteria, proof-of-concept benchmarks, and futility stopping rules
• Prepare and evaluate data packages and participate in FDA or EMA health authority discussions
• Tackle regulatory issues related to missing data, multiplicity, and bias
• Utilize benchmark data and simulation techniques to assess Probability of Technical Success
• Assist in decisions regarding pipeline prioritization, including advancing, partnering, or halting assets
• Master's or Ph.D. in Statistics, Biostatistics, or a related quantitative field
• Extensive experience within pharmaceutical, biotechnology, or CRO settings, particularly in oncology
• Proven track record in strategic drug development and clinical trial design that extends beyond traditional study-level duties
• In-depth understanding of oncology endpoints, adaptive designs, sample size/power calculations, simulations, and statistical methods
• Experience in supporting regulatory submissions and engaging with health authorities
• Exceptional communication and leadership abilities, with a talent for influencing senior cross-functional stakeholders
• Ongoing training and opportunities for professional growth
• Supportive management and training environment
• Commitment to equal opportunity and a diverse workplace
Ralliant
Bristol Myers Squibb
Zscaler
Illumina
Get handpicked remote jobs straight to your inbox weekly.